Table 2 VSIG1 pattern of expression is statistically significant correlated to regional lymph node status, lymph node ratio and Dukes-MAC-like stage, but not to tumor depth of invasion. At the same time, β-catenin and E-cadherin statuses are significantly different between the three VSIG1 patterns. Significant values are in bold.
VSIG1 homologous type I (n = 20) | VSIG1 homologous type II (n = 54) | VSIG1 heterologous (type A and B) (n = 20) | p value | |
|---|---|---|---|---|
Gender | ||||
Male | 16/80% | 39/72.22% | 18/90% | 0.254 |
Female | 4/20% | 15/27.78% | 2/10% | |
Age | ||||
≤ 60 | 6/30% | 8/14.81% | 5/25% | 0.294 |
> 60 | 14/70% | 46/85.19% | 15/75% | |
Lauren’s histologic subtype | ||||
Intestinal type | ||||
G2 Adeno-carcinoma | 11/55% | 27/50% | 8/40% | 0.356 |
G3 Adeno-carcinoma | 4/20% | 17/31.48% | 4/20% | |
Diffuse/poorly cohesive subtype | 5/25% | 10/18.52% | 8/40% | |
pT stage | ||||
Early pT (pT1–2) | 5/25% | 9/16.66% | 1/5% | 0.219 |
Advanced pT (pT3–4) | 15/75% | 45/83.34% | 19/95% | |
pN stage | ||||
N0 | 8/40% | 15/27.78% | 1/5% | 0.033 |
N1+ | 12/60% | 39/72.22% | 19/95% | |
pM stage | ||||
Mx | 19/95% | 42/77.78% | 16/80% | 0.224 |
M1 | 1/5% | 12/22.22% | 4/20% | |
Resection margins | ||||
R0 | 17/85% | 44/81.48% | 14/70% | 0.444 |
R1 | 3/15% | 10/18.52% | 6/30% | |
Lymphovascular invasion | ||||
LV0 | 6/30% | 12/22.22% | 2/10% | 0.292 |
LV1 | 14/70% | 42/77.78% | 18/90% | |
Perineural invasion | ||||
n0 | 10/50% | 21/38.88% | 5/25% | 0.264 |
n1 | 10/50% | 33/61.12% | 15/75% | |
Tumor budding in front of invasion | ||||
b1 | 5/25% | 10/18.52% | 2/10% | 0.462 |
b2 | 4/20% | 19/35.18% | 5/25% | |
b3 | 11/55% | 25/46.3% | 13/65% | |
Dukes-MAC-like stage | ||||
Early (A–B–C1) | 8/40% | 10/18.52% | 1/5% | 0.020 |
Advanced (C2–D) | 12/60% | 44/81.48% | 19/95% | |
Lymph node ratio | ||||
0.00 | 9/45% | 15/27.78% | 1/5% | 0.0022 |
0.01–0.25 | 6/30% | 16/29.62% | 2/10% | |
≥ 0.26 | 5/25% | 23/42.6% | 17/85% | |
EMT markers | ||||
β-catenin expression | ||||
Membrane | 19/95% | 48/88.9% | 11/55% | 0.0007 |
Nucleus | 1/5% | 6/11.1% | 9/45% | |
E-cadherin expression | ||||
Membrane | 18/90% | 47/87% | 11/55% | 0.004 |
Negative | 2/10% | 7/13% | 9/45% | |